Discover all the brand names or Trade names of generic drug called Insulin. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone looking to comprehend ...

Massachusetts is the latest state going after insulin makers and the intermediaries officials accuse of price gouging. Why it matters: Diabetes patients are often paying hundreds of dollars a month or ...

Despite being off-patent for many years, Humalog and other insulin brands continue to make high sales, with Lilly booking around $3 billion from its product last year, $1.8 billion of which was ...

Find all the commercial and brand names of generic drug called Insulin Aspart. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

This is down from $82, reports The New York Times. Lilly will also be reducing the price of its most prescribed insulin brands Humalog and Humulin by 70 percent. Humalog will be priced at $66.40 ...

Three U.S. Senators say they are "alarmed" Novo Nordisk discontinued U.S. sales of a popular insulin brand and are demanding answers from the pharmaceutical giant they say left patients without an ...

Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind schedule ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two ...